On Thursday, Gilead Sciences Inc says it expects to meet 'real-time global demand' for remdesivir by October and will produce two million treatment courses by the end of 2020.
from Home | Mail Online https://ift.tt/2DE7ard
Gilead says it has ramped up production of remdesivir by 50-fold
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Thanks For Comment We will Contact You With In 24 Hours